<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Harvard Bioscience, Inc.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware 04-3306140
---------------------------------------- ------------------------------------
(State of Incorporation or Organization) (I.R.S. Employer Identification no.)
84 October Hill Road, Holliston, Massachusetts 01746-1371
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
If this form relates to the If this form relates to the
registration of a class of securities registration of a class of securities
pursuant to Section 12(b) of the pursuant to Section 12(g) of the
Exchange Act and is effective Exchange Act and is effective
pursuant to General Instruction pursuant to General Instruction
A.(c), please check the following A.(d), please check the following
box. / / box. /X/
Securities Act registration statement file number to which
this form relates: 333-45996
---------------
(If applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
---------------------------------- ------------------------------
None
---------------------------------- ------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, Par Value $.01 Per Share
--------------------------------------
(Title of class)
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
A description of the Common Stock of the Registrant is set
forth in the information provided under "Description of
Capital Stock" in the Prospectus contained in the Registration
Statement on Form S-1 (the "Registration Statement"), filed
under the Securities Act of 1933 with the Securities and
Exchange Commission on September 18, 2000, File No. 333-45996,
as amended (including after the date hereof pursuant to Rule
424(b) under the Securities Act of 1933), which information is
incorporated herein by reference.
ITEM 2. EXHIBITS.
(1) Specimen certificate for shares of Common
Stock, par value $.01 per share, of the
Registrant (incorporated by reference to
Exhibit 4.1 to the Registration Statement).
(2) Form of Second Amended and Restated Certificate
of Incorporation of the Registrant
(incorporated by reference to Exhibit 3.2 to
the Registration Statement).
(3) Form of Amended and Restated By-laws of the
Registrant (incorporated by reference to
Exhibit 3.3 to the Registration Statement).
(4) Form of Amended and Restated Securityholders'
Agreement dated as of March 2, 1999 by and
among Harvard Apparatus, Inc., Pioneer Ventures
Limited Partnership, Pioneer Ventures Limited
Partnership II, Pioneer Capital Corp., First
New England Capital, L.P. and Citizens Capital,
Inc. and Chane Graziano and David Green
(incorporated by reference to Exhibit 4.2 to
the Registration Statement).
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the Registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
HARVARD BIOSCIENCE, INC.
By: /s/ James Warren
----------------------------------
James Warren
Chief Financial Officer
Dated: November 8, 2000
